News

The American College of Cardiology and American Heart Association have released an updated guideline for the management of patients with non-ST elevation ACS

13.10.20142270

The societies have adopted the term non-ST elevation ACS to refer to patients with unstable angina or non-STEMI because “at presentation, [they] can be indistinguishable and are therefore considered together,” Ezra A. Amsterdam, MD, FACC, chair of the writing committee, and colleagues wrote.

New LDL-lowering therapy safe, effective in phase 2b trial

10.10.20141889

Esperion Therapeutics announced favorable top-line results from a phase 2b study assessing the safety and efficacy of a treatment for patients with hypercholesterolemia.

Go Red for Women: Results

09.10.20142998

В Москве завершилась акция «Оденься в красное!», прошедшая под эгидой Российского кардиологического общества, социально-образовательной программы «Пульс жизни» и концерна Bayer.

Long-Term Clinical Outcome of Major Adverse Cardiac Events in Survivors of Infectious Endocarditis: A Nationwide Population-Based Study

09.10.20141612

Substantial infective endocarditis (IE)-related morbidity and mortality may occur even after successful treatment.

Outcomes After Emergency Percutaneous Coronary Intervention in Patients With Unprotected Left Main Stem Occlusion: The BCIS National Audit of Percutaneous Coronary Intervention 6-Year Experience

08.10.20141695

What are the in-hospital outcomes and 3-year mortality of patients presenting with unprotected left main stem occlusion (ULMSO) treated with primary percutaneous coronary intervention (PPCI)?

Heart Failure as a Risk Factor for Diabetes Mellitus

07.10.20141584

Diabetes mellitus (DM) is a well-recognized risk factor for heart failure (HF).

High-Sensitivity Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) and Risk of Incident Heart Failure in Patients with CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study

06.10.20141670

High-sensitivity troponin T (hsTnT) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) strongly predict heart failure (HF) in the general population.